Condensed Consolidated Statements of Changes in Equity (Unaudited) (USD $)	Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning Balance Amount at Jun. 30, 2013	$ 0	$ 885,389	$ 85,464,055	$ (80,932,823)	$ (1,594,418)	$ 2,304,121
Beginning Balance Shares at Jun. 30, 2013	0	17,707,431
Net loss				(8,855,418)		(657,881)
Net currency translation adjustment					(5,457)
Issuance of warrants			498,793
Issuance of common stock, net of costs and underwriting fees, Shares		6,325,000
Issuance of common stock, net of costs and underwriting fees, Amount		63,250	12,973,214
Issuance of preferred stock, net of costs and underwriting fees, Shares	3,000
Issuance of preferred stock, net of costs and underwriting fees, Amount	30		2,388,756
Issuance of warrants to underwriter			15,455
Stock-based compensation, Shares		245,570
Stock-based compensation, Amount		2,456	959,905
Conversion of preferred stock, Shares	(425)	470,171
Conversion of preferred stock, Amount	(4)	4,701	(4,696)
Exercise of warrants, Shares		903,217
Exercise of warrants, Amount		9,032	(9,032)
Ending Balance Amount at Jun. 30, 2014	26	964,828	102,286,450	(89,788,241)	(1,599,875)	1,646,240
Ending Balance Shares at Jun. 30, 2014	2,575	25,651,389
Net loss				(9,472,006)		118,649
Net currency translation adjustment					12,242
Issuance of common stock, net of costs and underwriting fees, Shares		13,248,000
Issuance of common stock, net of costs and underwriting fees, Amount		132,480	13,557,257
Stock-based compensation, Shares		201,820
Stock-based compensation, Amount		2,019	1,154,701
Contribution of capital from noncontrolling interest						13,756
Ending Balance Amount at Mar. 31, 2015	$ 26	$ 1,099,327	$ 116,998,408	$ (99,260,247)	$ (1,587,633)	$ 1,778,645
Ending Balance Shares at Mar. 31, 2015	2,575	39,101,209